Physician profile
Pankil Vora
NPI 1447269535
$1,560.06
in general payments reported to CMS, 2019-2025
19 companies · $15.60 in 2025
The $15.60 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $355 · 2021: $443 · 2022: $388 · 2023: $44.41 · 2025: $15.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $60.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $60.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $634.88 | 2019-2025 | Airsupra |
| Abbvie INC. | $275.03 | 2019-2023 | Ubrelvy |
| Janssen Pharmaceuticals, INC | $123.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $96.99 | 2019-2021 | |
| Pfizer INC. | $85.75 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.63 | 2019-2021 | |
| Amarin Pharma, INC. | $30.99 | 2019 | |
| Merck Sharp & Dohme LLC | $28.06 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $27.72 | 2019-2020 | |
| Novo Nordisk INC | $27.20 | 2020-2021 | |
| Lilly USA, LLC | $25.62 | 2020 | |
| Exact Sciences Corporation | $23.43 | 2023 | Cologuard Collection Kit |
| Endo Pharmaceuticals INC. | $22.44 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.10 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $13.87 | 2019 | |
| Astellas Pharma US INC | $13.48 | 2020 | |
| Vanda Pharmaceuticals INC. | $12.28 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankil Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.